Erythropoietin-derived peptide (HBSP) inhibits caspase-3/GSDME through HMGB1 to regulate pyroptosis and reduce diabetic retinopathy

Zhiyong Zheng, Qing Liu, Xu Chen, Muzhen Huang, Qing Ye, Min Chen

Open source

DOI
10.1016/j.peptides.2026.171520
Published
2026-09
Container
Peptides
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.peptides.2026.171520,
  title = {Erythropoietin-derived peptide (HBSP) inhibits caspase-3/GSDME through HMGB1 to regulate pyroptosis and reduce diabetic retinopathy},
  author = {Zhiyong Zheng and Qing Liu and Xu Chen and Muzhen Huang and Qing Ye and Min Chen},
  year = {2026},
  journal = {Peptides},
  doi = {10.1016/j.peptides.2026.171520},
  url = {https://doi.org/10.1016/j.peptides.2026.171520}
}

RIS

TY  - JOUR
TI  - Erythropoietin-derived peptide (HBSP) inhibits caspase-3/GSDME through HMGB1 to regulate pyroptosis and reduce diabetic retinopathy
AU  - Zhiyong Zheng
AU  - Qing Liu
AU  - Xu Chen
AU  - Muzhen Huang
AU  - Qing Ye
AU  - Min Chen
PY  - 2026
JO  - Peptides
DO  - 10.1016/j.peptides.2026.171520
UR  - https://doi.org/10.1016/j.peptides.2026.171520
ER  - 

APA

Zheng, Z., Liu, Q., Chen, X., Huang, M., Ye, Q., & Chen, M. (2026). Erythropoietin-derived peptide (HBSP) inhibits caspase-3/GSDME through HMGB1 to regulate pyroptosis and reduce diabetic retinopathy. Peptides. https://doi.org/10.1016/j.peptides.2026.171520

Source records